Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for sedation in painless gastroscopy
ChiCTR2000034901Phase 4Not yet recruiting
- Sponsor
- Chengdu Second People's Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, propofol and butorphanol in None (2 arms), sponsored by Chengdu Second People's Hospital. Primary endpoint: MOAA/S score. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
remimazolampropofolbutorphanol
Beyond the preview
Go deeper on ChiCTR2000034901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034901.